INS and diabetes mellitus: Diabetes mellitus, a metabolic disorder characterized by hyperglycemia due to inadequate insulin secretion and utilization [222, 223], involves non‐Hippo pathway‐dependent YAP activation, which drives the progression of diabetes‐related atherosclerosis.